Premium
Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease
Author(s) -
Lim Seah H.,
Dutta Dibyendu
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25798
Subject(s) - rifaximin , medicine , gastroenterology , enterocyte , cirrhosis , antibiotics , immunology , small intestine , microbiology and biotechnology , biology